Clinical Trials | American Lung Association

KEAPSAKE

A Phase 2 Randomized, Multicenter, Double-Blind Study of the Glutaminase Inhibitor Telaglenastat with Pembro and CTX Versus Placebo with Pembro and CTX in 1L, Metastatic KEAP1/NRF2-Mutated, Nonsquamous NSCLC

LUNAR

To test the efficacy and safety of TTFields, using the NovoTTF-100L system, concurrent with standard therapies for stage 4 NSCLC patients, following progression while on or after platinum based treatment.

Lung Cancer Study

This is a research study that is aimed at finding the location of gene(s) that may increase the risk of lung cancer in some families.

Lung-MAP (Lung Cancer Master Protocol) (SWOG S1400)

Lung-MAP is a multi-arm trial designed to test several different therapies simultaneously. MEDI4736, GDC-0032, Palbociclib, and AZD4547 are currently being studied, but the trial protocol could allow new therapies to be added in the future.

LYT-100 in Post-acute COVID-19 Respiratory Disease

To evaluate the safety and efficacy of LYT-100 with post-acute COVID-19 respiratory complications who were treated with, but no longer require mechanical ventilation, extracorporeal membrane oxygenation, non-invasive ventilation (eg CPAP or BiPAP), high-flow nasal oxygen therapy, or combination thereof.

PrecISE

RELIANCE

RELIANCE is multi-site pragmatic study to compare long-term roflumilast use with long-term azithromycin use in people who have COPD with chronic bronchitis who have been hospitalized in the past year.

Sarilumab in Patients With Glucocorticoid-Dependent Sarcoidosis

The purpose of this study is to compare the effectiveness and the safety of sarilumab in patients with glucocorticoid-dependent sarcoidosis.

SYNERGY-AI

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

TRS003 Bevacizumab

A Phase 3, Multicenter, Randomized and Double-Blind Study to Assess the Similarity in Efficacy and Safety Between TRS003 and China-approved Bevacizumab in Subjects With Advanced Nonsquamous NSCLC.